Innoviva (INVA) Income from Continuing Operations (2010 - 2026)
Innoviva's Income from Continuing Operations was -$83.42 million in Q2 2026, compared with $63.69 million a year earlier.
Powered by 
Analysis
Innoviva (INVA) Income from Continuing Operations (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innoviva's Income from Continuing Operations was $357.2 million through Jun 30, 2026, up 824.3% year-over-year; for FY2025, it was $271.17 million.
- Income from Continuing Operations shows a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- In earlier years, Income from Continuing Operations was $23.39 million in FY2024 (-87.0%), $179.72 million in FY2023 (-18.4%), $220.26 million in FY2022 (-40.3%) and $368.84 million in FY2021 (+25.5%).
- The Q2 2026 figure marks the lowest quarterly Income from Continuing Operations in data going back to Q2 2010.
- The best year-over-year quarter for Income from Continuing Operations over five years was Q4 2025 (growth of 707.4%); the worst was Q2 2023 (a decline of 94.0%).
- Per Business Quant data, INVA's Income from Continuing Operations in the three quarters before Q2 2026 was $186.56 million (Q1 2026), $164.15 million (Q4 2025) and $89.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | -83.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.42 Mn |
| Mar 31, 2026 | 186.56 Mn |
| Dec 31, 2025 | 164.15 Mn |
| Sep 30, 2025 | 89.91 Mn |
| Jun 30, 2025 | 63.69 Mn |
| Mar 31, 2025 | -46.59 Mn |
| Dec 31, 2024 | 20.33 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | -34.68 Mn |
| Mar 31, 2024 | 36.52 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 34.84 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 229.32 Mn |
| Jun 30, 2022 | 21.40 Mn |
| Mar 31, 2022 | 37.82 Mn |
| Dec 31, 2021 | 45.65 Mn |
| Sep 30, 2021 | 102.65 Mn |
| Jun 30, 2021 | 110.85 Mn |
API Access
Innoviva Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();